FOUNTAIN INN, S.C., Jan. 5, 2016 (GLOBE NEWSWIRE) -- AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has introduced the new T4C Series HRC4000 medical grade, solid tantalum microchip capacitors. Designed for use in the filtering, hold-up, timing, and pulsing circuits within implantable, non-life-support and non-implantable life support applications, the T4C Microchip Medical Series delivers the smallest medical tantalum capacitors available in the industry (0402 case sizes) with low DC leakage levels (0.01CV or 0.3μA), in addition to change control for consistent supply and high standard reliability better than 0.1% failures per 1,000 hours, which is 10 times better than standard commercial reliability.
T4C Microchip Medical Series capacitors are manufactured and tested using AVX's patented and extremely effective Q-Process technology, which was developed to replace the Weibull Reliability Assessment as the industry standard for tantalum capacitors due to its tendency to burn-in potentially unstable units. In use since 2013, the Q-Process effectively removes components that may experience parametric shifts through customer processing or display instability through life testing, ensures stable and normalized DCL distribution, and provides reliability level verification through life testing to a minimum of 0.1% per 1,000 hours with a 90% confidence level.
"Due to the critical nature of their successful operation, medical implantable, non-life-support and non-implantable life support applications demand electronic components capable of satisfying rigorous performance requirements, including exceptionally high reliability and low DCL," said Brian Brunette, high reliability tantalum applications engineer, AVX. "As the market leader in solid tantalum, medical grade components, our new T4C Microchip Medical Series capacitors deliver unparalleled quality at competitive prices, providing customers with high standard reliability and low DC leakage levels in the smallest medical tantalum case sizes available."
T4C Microchip Medical Series capacitors are currently available in three case sizes (0402, 0603, and 0805), four rated voltages (4V, 6.3V, 10V, and 16V), and with two levels of statistical screening: T4C Standard for standard DCL and ESR limits, and T4C Custom for specific DCL and ESR parameter limits — down to 0.005CV on selected codes. Capacitance values for the series span 0.47μF to 22μF with a ±10% or ±20% capacitance tolerance, and rated operating temperatures range from 55°C to +125°C. Lead-free compatible and RoHS compliant, T4C Series capacitors are available with gold-plated or 100% tin terminations, and packaged in bulk or on 7" or 4.25" reels. Lead time for the series is 10–12 weeks.
For more information about this certification, or to request a specific rating, please contact the factory by calling 207-282-5111.
For more information about AVX's new T4C Series HRC4000 medical grade, solid tantalum microchip capacitors, please visit http://www.avx.com/products/tantalum/high-reliability/medical/t4c-microchip-medical-series/ to access the product datasheet, AVX's High Reliability Tantalum Capacitors catalog, technical and part number information, modeling software, and relevant technical papers, including "Reaching the Highest Reliability for Tantalum Capacitors," which provides in-depth information about AVX's patented Q-Process. For all other inquiries, please visit www.avx.com, call 864-967-2150, or write to One AVX Boulevard, Fountain Inn, S.C. 29644.
About AVX
|
|||||
AVX Corporation is a leading international supplier of electronic passive components and interconnect solutions with 20 manufacturing and warehouse facilities in 11 countries around the world. AVX offers a broad range of devices including capacitors, resistors, filters, timing and circuit protection devices, and connectors. The company is publicly traded on the New York Stock Exchange (NYSE:AVX).
A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=38320
CONTACT: Brian Brunette
Applications Engineer, AVX
207-286-2181
[email protected]
Christine Stieglitz
PR Executive, BtB Marketing
919-872-8172
[email protected]


Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
First Western Ship Transits Strait of Hormuz Since Iran War Began
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation 



